🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07046143
Enrolling by invitation

Study on the Efficacy of Non-invasive Spinal Cord Electrical Stimulation in Neuropathic Pain

NCT07046143 · tracked via the Priya Life Science China tracker
Sponsor
Nanchang University Affiliated Rehabilitation Hospital
Phase
N/A
Started
2025-06-25
Last updated
2025-12-22

Condition(s) studied

Neuropathic Pain

Investigational drug(s) / intervention(s)

tSCS

tSCS: The test group received non-invasive spinal cord electrical stimulation therapy during hospitalization. Patients were positioned prone or seated, with the anode placed above the iliac crest on the affected side and the cathode covering the paravertebral region of the lumbosacral enlargement corresponding to the painful dermatome. The stimulation frequency was adjusted to 10,000 Hz, with a treatment frequency of 30 Hz and a pulse width of 1 millisecond. The waveform was square, with each treatment session lasting 20 minutes. Stimulation intensity was set to the patient's tolerable threshold. Sessions were administered twice daily, each lasting 20 minutes.

Study summary

This study is a randomized, double-blind, controlled clinical trial designed to evaluate the impact of non-invasive spinal cord electrical stimulation (tSCS) on the outcome of patients with neuropathic pain.Subjects will be randomized into a test group (treated with tSCS) and a control group (receiving sham stimulation).The intervention period was during the patient's hospitalization, with a follow-up period of 3 months.Patients' pain and quality of life will be assessed at baseline, at the end of the intervention, and during the follow-up period to compare the difference in efficacy between the two groups.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * Age 18-80 years old; * Meet the diagnostic criteria for neuropathic pain * Chronic low back pain due to neuropathic pain, with or without leg pain; * The skin at the site of irritation is intact; * The patient's vital signs are stable. Exclusion Criteria: * Pain is mainly caused by non-neuropathic factors, such as acute inflammation and trauma; * Those with severe mental illness affecting the study assessment, those with severe cognitive impairment unable to communicate normally or with very poor compliance; * Accompanied by severe cardiac, hepatic, renal and other vital organ insufficiency; * Recently received other related treatments that may affect the impact of neuropathic pain.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
NanChang Nanchang Jiangxi
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07046143 on ClinicalTrials.gov ↗ ← All trials in China